Vascular Solutions, Inc. (NASDAQ:VASC)
A medical device company focused on bringing clinically advanced solutions to interventional cardiologists and interventional radiologists worldwide.
- Quote
- Commentary
- Scorecard
- Historical Prices
- Chart
- Stats
- Ratios
- Earnings/Growth Rates
- Statements
- SEC Filings
Recs
Vascular Solutions are must in hospitals. I agree to more speed in giving surgical/medicinal solutions that this company can give. Many patients seek the care that this company can give.
Recs
by buying other companies and effectively digesting (using) them, vasc will be a better company.
Recs
Recs
Price/earnings of 8.72, market cap of 185.70 million, debt/equity of zero, Return on Invested Capital (TTM) of 40.91, based in Minnesota, United States, medical device company with focus on equipment for interventional cardiologists and interventional radiologists.
Recs
Long-term pick. They have a PE of 10 and good insider ownership.
Recs
Came across this stock while researching Abbot Labs. The rapid growth in vascular medicine shouldn't be surprising given the declining health of your average American over the last several years. I don't imagine this growth will slow any time soon and unlike your less invasive vascular treatments, medical devices aren't subject to threats from generic competition. The spread on VASC, however, is huge and being a microcap and all is probably too risky to buy in RL but the numbers certainly look good. As per usual, I'll be tracking this on CAPS for now and if the opportunity presents itself I may consider starting a position. The potential here is enormous.
Recs
The company has no debt and the margin is consistent. Asset growth is consistent and cash flow is positive.
Recs
This stock is a hidden gem, going to buy and hold this one for 2-4 years+. Entry point in the 8 range and if it takes a dip to 6 i'm just going dca down and double my investment. Love the niche market, great growth rates, balance sheet and expanding product line. Micro cap status would prevent this vascular product line of even making a splash on an abt or jnj scale at this range, however, if growth continues this will be a buyout target at some point in time or worst case scenario be a market outperform.
Recs
Recs
They have money. They don't owe money. They're making money. They make cutting edge medical products. Their webpage slogan is: unique solutions for unmet medical needs. That sounds like money. I'm on board. No, I don't work there and I'm not on the board of directors. just a company I found with some due dilligence.
Revenue growth chart is very juicy. I'm putting some coin in this one. Again, not a very sexy stock, but not every stock is POT, MOS, TC or AGR. I think you can wait on this one for a little while while you make money off fertilizer, but if you're looking to diversify, (and this coming from a guy who is in big with TC so take it for what is worth) I think this is a nice little medical play at a nice price. I think at some point people are going to take notice of this company and it'll either get bought or break out.
Recs
This is a good company with carefull management that is doing well despite the current economic environment.The basic for the company are good and it is not very leveraged.
Recs
RSS Headlines
Fool UK
- Show Me:
-
Outperform
-
Underperform
-
All
- Sort by:
-
Author
-
Recs
-
Date
-
Member Rating
-
Results 1 - 12 of 12